IP Library Granted Patent US 11,844,840
Granted Patent B2
US 11,844,840 · App. 17/828,640 · Granted Dec 19, 2023

Compositions and methods for increasing efficiency of cardiac metabolism

Inventor: Andrew D. Levin (Newton, MA)
Assignee: IMBRIA PHARMACEUTICALS, INC.
A61K47/551A61K31/495A61K47/55A61K47/60C07D401/12A61P3/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,844,840
App. No.
17/828,640
Granted
Dec 19, 2023
Kind
B2
Abstract

Compositions and methods for increasing efficiency of cardiac metabolism are provided.

Claims (5)

1. A method of treating heart failure in a subject suffering from heart failure, the method comprising providing to the subject a compound represented by formula (X):

2. The method of claim 1 , wherein the compound is provided as a pharmaceutical composition.

3. The method of claim 2 , wherein the pharmaceutical composition is provided to the subject orally.

4. The method of claim 3 , wherein the pharmaceutical composition comprises a format selected from the group consisting of a tablet, troche, lozenge, fast-melt, aqueous suspension, oily suspension, dispersible powder, granule, emulsion, hard capsule, soft capsule, syrup, and elixir.

5. The method of claim 1 , wherein the compound is provided to the subject at a dosage of from about 1 mg/kg/day to about 10 mg/kg/day.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2022
From: LEVIN, ANDREW
To: RA CAPITAL MANAGEMENT, LLC
Reel/Frame 060701/0271 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2022
From: RA CAPITAL MANAGEMENT, LLC
To: CARNOT, LLC
Reel/Frame 060701/0284 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2022
From: CARNOT, LLC
To: IMBRIA PHARMACEUTICALS, INC.
Reel/Frame 060701/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2022
From: CARNOT, LLC
To: IMBRIA PHARMACEUTICALS, INC.
Reel/Frame 060701/0320 →
Continuity (9)
Division 17074877 · Oct 20, 2020
Continuation 16722754 · Dec 20, 2019
Continuation 16011196 · Jun 18, 2018
Provisional Application 62647926 · Mar 26, 2018
Provisional Application 62637434 · Mar 2, 2018
Provisional Application 62710316 · Feb 16, 2018
Provisional Application 62524237 · Jun 23, 2017
Provisional Application 62522214 · Jun 20, 2017
Related Publication 20220288215A1 · Sep 15, 2022
Cited By (2)
US 12,318,382 US 12,318,453